ACORDA THERAPEUTICS, INC. ACOR Balance Sheet

Acorda therapeutics, inc. (ACOR)

Balance Sheet / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Dec'09
Assets
Current assets:
Cash and cash equivalents
32,417	62,085	119,521	147,648	197,093	293,564	321,011	243,345	226,276	307,068	192,496	141,135	133,619	158,537	127,940	137,400	431,414	153,204	89,837	76,197	61,515	182,170	53,341	274,599	44,355	48,037	46,266	42,702	34,687	41,876	40,026	64,717	55,300	57,954	44,385	48,635	78,457	34,641	82,404	75,668	47,314
Restricted cash
13,175	12,836	387	192	567	532	365	221	460	410	68	-	61	79	-	-	190	6,032	1,139	900	1,243	1,205	194	-	259	277	136	41	34	380	469	303	303	303	303	302	302	302	301	301	301
Short term investments
50,500	63,800	133,600	149,200	146,157	152,000	139,935	148,371	106,767	0	-	-	-	-	-	-	-	200,101	233,593	225,523	238,182	125,448	713,100	331,254	226,065	225,891	246,043	260,627	248,659	191,949	192,204	191,133	222,945	237,953	224,428	179,565	146,890	205,389	163,412	140,769	224,778
Trade accounts receivable, net of allowances of $498 and $682, as of March 31, 2020 and December 31, 2019, respectively
14,969	22,083	17,553	21,010	20,652	23,430	51,461	64,360	50,787	81,403	53,825	55,626	50,238	52,239	48,575	45,886	41,623	31,466	31,755	29,797	30,551	32,211	24,792	27,027	29,265	30,784	24,998	27,055	23,288	26,327	23,227	23,607	21,526	22,828	20,608	23,416	23,795	22,272	18,228	17,925	5,739
Prepaid expenses
27,395	11,574	11,839	9,850	14,223	19,384	16,221	15,101	14,782	13,333	9,757	10,190	13,615	12,907	15,639	18,709	14,312	16,079	13,876	18,526	19,050	15,523	9,000	8,272	8,101	8,398	8,617	7,096	7,606	6,936	8,180	8,655	8,201	6,534	7,099	7,457	7,098	6,413	5,722	5,524	4,274
Inventory, net
25,566	25,221	27,396	28,086	31,465	29,014	10,800	21,147	27,662	37,501	39,870	43,914	46,054	43,135	40,935	55,553	39,667	36,476	46,838	48,649	45,268	26,256	26,645	30,821	30,545	25,535	25,574	30,996	27,850	20,176	18,406	28,494	27,614	27,256	28,617	40,080	42,595	36,232	24,079	17,858	4,497
Finished goods inventory held by others
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	553	563	581	570	580	609	637	671	694	736	781	834	919	1,045	1,126	1,152	2,065	2,200	2,186	2,101	2,156	2,394
Deferred tax asset
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,967	19,321	20,469	-	5,873	10,452	16,493	19,314	28,940	32,935	36,955	35,091	-	-	-	-	-	-	-	-	-	-	-
Other current assets
4,286	3,560	4,005	2,342	7,747	10,194	6,802	2,007	1,454	1,983	7,399	4,744	4,565	5,760	4,863	5,616	17,075	7,959	7,563	8,167	6,995	7,324	10,374	10,124	7,727	8,460	6,558	10,759	11,060	9,547	9,483	9,409	10,780	6,988	7,781	4,333	4,343	3,734	3,260	3,574	3,980
Total current assets
168,285	201,113	314,337	358,370	417,904	528,107	546,595	494,552	428,188	441,698	303,415	255,609	248,152	272,657	237,952	263,164	544,281	451,317	429,568	427,633	423,836	390,718	843,889	693,129	363,419	367,333	387,803	412,905	390,875	333,063	292,829	327,237	347,714	360,942	334,373	305,853	305,680	311,169	299,512	263,780	293,280
Long-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	121,855	101,732	93,299	57,069	29,050	41,559	99,363	86,434	47,118	17,046	-	-	-	-	-	-	-	-
Property and equipment, net of accumulated depreciation
142,500	142,527	130,585	113,455	83,032	60,519	52,061	42,524	39,023	36,669	36,484	37,368	37,132	34,310	35,777	36,754	38,027	40,204	42,415	44,453	45,919	46,090	17,089	15,823	16,440	16,525	17,752	17,740	16,936	16,706	16,437	14,290	6,521	3,858	3,595	3,543	3,594	3,203	3,320	2,787	1,891
Goodwill
-	-	0	281,467	280,128	282,059	283,435	284,100	289,577	286,611	285,317	281,896	278,069	280,599	284,029	284,504	183,636	183,636	183,636	182,952	182,952	182,952	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax asset
-	-	-	-	-	-	-	-	-	-	4,400	4,400	4,400	4,400	2,951	2,128	12,273	2,128	-	-	-	2,806	84,885	84,885	107,985	107,985	101,725	101,453	101,545	101,636	-	-	-	-	-	-	-	-	-	-	-
Intangible assets, net of accumulated amortization
390,311	402,329	410,023	418,000	425,777	428,570	428,575	428,762	429,791	430,603	705,141	742,704	740,838	742,242	749,415	751,524	430,491	430,856	431,279	431,759	432,155	432,822	16,865	17,281	17,959	17,459	17,590	9,875	9,446	9,319	9,279	8,755	8,950	8,769	7,053	20,502	20,707	21,336	22,013	22,657	17,148
Right of use asset, net of accumulated amortization
22,450	23,450	24,675	25,876	26,802	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash
30,270	30,270	-	-	-	255	-	-	-	-	-	-	-	-	-	-	-	-	4,809	4,809	4,809	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-current portion of deferred cost of license revenue
-	-	-	-	-	-	-	-	-	1,638	1,796	1,955	2,113	2,272	2,430	2,589	2,747	2,906	3,064	3,223	3,381	3,540	3,698	3,857	4,015	4,174	4,332	4,491	4,649	4,808	4,967	5,125	5,283	5,442	5,600	5,759	5,917	6,050	6,215	6,380	6,710
Other assets
11	29	293	294	295	156	419	678	494	750	8,505	8,510	9,138	5,855	5,814	5,876	239	247	5,507	5,721	5,930	6,137	6,341	6,487	337	352	376	392	413	437	507	528	538	477	477	438	309	343	359	382	440
Total assets
753,827	799,718	879,913	1,197,462	1,233,938	1,299,666	1,311,085	1,250,616	1,187,073	1,197,969	1,345,058	1,332,442	1,319,842	1,342,335	1,318,368	1,346,539	1,211,694	1,111,294	1,100,278	1,100,550	1,098,982	1,065,065	972,767	943,317	611,887	607,127	586,647	575,906	565,423	565,332	410,453	403,053	386,052	379,488	351,098	336,095	336,207	342,101	331,421	295,987	319,470
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
12,073	26,257	26,777	26,724	25,955	48,859	29,554	15,400	18,377	27,367	21,741	19,967	21,378	26,933	18,557	29,554	21,355	14,233	14,005	16,947	21,886	17,751	20,507	20,660	21,506	15,922	15,907	21,189	24,077	22,503	18,460	19,721	20,010	21,393	13,943	16,706	19,184	16,961	17,363	7,124	11,613
Accrued expenses and other current liabilities
36,968	39,077	43,235	44,594	45,918	76,882	97,816	97,761	91,782	99,850	78,304	77,503	88,146	104,890	89,374	96,388	73,475	66,133	68,472	55,535	60,208	56,118	39,785	34,064	31,331	37,569	29,920	34,211	31,786	35,758	23,243	28,205	20,487	24,149	19,239	24,998	25,774	33,769	25,803	17,351	14,975
Deferred product revenue-Zanaflex
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28,403	29,121	29,420	29,515	29,462	31,217	32,090	31,221	30,085	29,620	29,275	9,941	9,910	9,959	30,599	9,918	9,819	9,694	9,526	8,709	8,631	9,214
Current portion of deferred license revenue
-	-	-	-	-	-	-	-	-	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,057	9,429	9,428	9,428	9,428
Current portion of loans payable
592	603	587	612	604	616	624	629	663	645	636	615	754	6,256	-	-	-	25	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of liability related to sale of future royalties
11,209	10,836	9,811	9,384	9,173	8,985	7,714	7,081	6,536	6,763	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of lease liabilities
7,846	7,746	7,696	7,644	7,458	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of acquired contingent consideration
1,940	1,866	3,887	4,993	8,179	4,914	-	-	-	278	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred product revenue-Zanaflex Capsules
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	18,859	19,081	20,196	-	19,401	19,055	21,242	21,770	20,617	20,534	21,489
Current portion of revenue interest liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	561	585	749	893	913	225	450	861	1,009	1,174	1,180	1,134	1,335	1,315	1,204	1,001	1,735	1,797	1,979	1,297	6,381	6,551	6,178
Current portion of convertible notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	765	1,134	1,126	1,117	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	1,144	0
Total current liabilities
70,628	86,385	91,993	93,951	97,287	140,256	135,708	120,871	117,358	143,960	109,738	107,142	119,335	147,901	118,122	136,125	105,004	90,592	93,239	111,671	122,165	114,383	100,921	94,612	94,705	96,643	88,258	96,860	96,864	98,871	82,039	88,433	82,057	87,343	74,437	82,576	88,074	93,896	89,448	70,766	72,900
Convertible senior notes
195,349	192,774	326,381	323,780	321,210	318,670	316,160	313,679	311,228	308,805	306,411	304,045	301,706	299,395	297,111	294,854	292,624	290,420	293,492	291,538	289,607	287,699	285,825	283,948	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Derivative liability
32,881	59,409	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-current portion of acquired contingent consideration
74,460	78,434	107,313	157,544	167,221	163,086	131,229	109,174	117,983	112,722	88,900	89,300	82,900	72,100	75,400	71,700	69,700	63,500	60,000	56,800	55,700	52,600	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-current portion of lease liabilities
21,757	22,996	24,393	25,766	26,455	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-current portion of deferred license revenue
-	-	-	-	-	-	-	-	-	23,398	25,663	27,927	30,191	32,456	34,720	36,984	39,249	41,513	43,777	46,042	48,306	50,570	52,835	55,099	57,363	59,628	61,892	64,156	66,421	68,685	70,949	73,214	75,478	77,742	80,007	82,271	84,535	86,429	88,785	91,142	95,857
Non-current portion of loans payable
24,713	25,495	24,518	25,237	24,643	24,470	24,673	24,698	25,900	25,670	25,174	24,052	24,660	24,635	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Put/call liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	167	167	-	-	-	247	329	554	511	495	1,030	1,457	374	391	391	318	318	637
Non-current portion of revenue interest liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14	258	344	-	659	753	891	1,111	1,247	1,537	1,908	1,898	2,618	2,986	3,329	3,586	4,374	4,982	5,630
Non-current portion of convertible notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,107	1,091	1,074	1,058	2,184	2,159	2,135	2,111	3,228	3,196	3,165	3,133	4,244	4,205	4,165	4,126	5,230	5,183	5,136	5,090	6,185	6,132	6,078	7,112
Deferred tax liability
16,391	9,581	2,804	3,069	5,401	7,483	70,656	37,586	24,936	22,459	98,537	79,556	76,130	92,807	91,429	89,960	12,146	12,146	24,568	23,885	23,885	8,271	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-current portion of liability related to sale of future royalties
10,964	13,565	16,437	18,491	20,174	21,731	24,251	26,102	27,859	29,025	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other non-current liabilities
10	259	4,732	4,787	4,961	11,987	9,783	11,871	11,884	11,943	10,645	10,700	8,793	8,830	34,820	35,374	8,959	8,991	9,223	9,256	9,241	9,103	8,100	6,719	6,677	7,275	6,251	6,174	6,228	6,171	5,992	5,543	2,894	1,036	480	-	-	353	-	-	-
Commitments and contingencies
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	-	-	-
Stockholders’ equity:
Preferred stock, $0.001 par value. Authorized 1,000,000 shares at March 31, 2020 and December 31, 2019; no shares issued as of March 31, 2020 and December 31, 2019, respectively
-	-	-	-	-	-	0	0	0	-	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common stock, $0.001 par value. Authorized 80,000,000 shares at March 31, 2020 and December 31, 2019; issued 47,734,146 and 47,730,396 shares, including those held in treasury, as of March 31, 2020 and December 31, 2019, respectively
48	48	48	48	48	48	47	47	47	46	47	47	47	46	46	46	46	43	43	43	43	42	41	41	41	41	41	40	40	40	39	39	39	39	39	39	39	39	38	38	37
Treasury stock at cost (29,304 shares at March 31, 2020 and December 31, 2019)
638	638	638	638	2,185	2,133	1,976	1,976	1,591	389	389	389	329	329	329	329	329	329	329	329	329	329	329	329	329	329	329	329	329	329	329	329	329	329	329	329	-329	329	-	-	0
Additional paid-in capital
981,364	979,388	1,015,037	1,011,744	1,008,796	1,005,105	999,880	993,292	977,881	968,580	957,543	949,344	937,665	921,365	911,540	904,784	894,167	812,782	793,774	783,128	772,892	761,026	743,776	733,265	688,105	678,686	670,855	656,784	647,507	640,671	633,184	627,069	621,053	614,914	609,312	603,973	595,796	591,649	586,058	578,845	565,503
Accumulated deficit
-673,281	-666,809	-732,469	-468,934	-441,448	-393,843	-403,439	-389,527	-435,725	-455,108	-284,148	-258,953	-250,757	-243,970	-240,876	-228,152	-209,872	-209,352	-218,557	-222,498	-223,495	-220,410	-220,741	-232,694	-237,379	-238,082	-244,274	-251,751	-255,662	-254,523	-387,496	-397,090	-401,635	-409,481	-422,175	-441,043	-440,758	-440,086	-443,757	-456,194	-428,316
Accumulated other comprehensive (loss) income
-819	-1,169	-636	2,617	1,375	2,806	4,113	4,799	9,313	6,858	6,937	-329	-10,499	-12,901	-3,615	-4,711	-	-119	-43	-60	-91	-74	166	96	82	37	98	54	83	62	69	-39	-34	66	69	112	40	-12	22	9	108
Total stockholders’ equity
-	-	-	-	566,586	-	598,625	606,635	549,925	519,987	679,990	689,720	676,127	664,211	-	681,542	-	603,025	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Noncontrolling interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,904	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total stockholders’ equity
306,674	310,820	281,342	544,837	-	611,983	-	-	-	-	-	-	-	-	666,766	671,638	684,012	-	574,888	560,284	549,020	540,255	522,913	500,379	450,520	440,353	426,391	404,798	391,639	385,921	245,467	229,650	219,094	205,209	186,916	162,752	154,788	151,261	142,361	122,698	137,332
Total liabilities and stockholders’ equity
753,827	799,718	879,913	1,197,462	1,233,938	1,299,666	1,311,085	1,250,616	1,187,073	1,197,969	1,345,058	1,332,442	1,319,842	1,342,335	1,318,368	1,346,539	1,211,694	1,111,294	1,100,278	1,100,550	1,098,982	1,065,065	972,767	943,317	611,887	607,127	586,647	575,906	565,423	565,332	410,453	403,053	386,052	379,488	351,098	336,095	336,207	342,101	331,421	295,987	319,470